Neudle.com: dystonia parkinsonism

Differential
(Click to cross reference)

aciduria

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome-related complex

adolescent medicine

advances in neurology

adverse drug reaction

agitation

akathisia

akinesia of eyelid function

alcohol

algorithm

alien hand syndrome

alternating hemiplegia

alternating hemiplegia of childhood

anti basal ganglia antibodies

anti IgLON5

anticholinergic drugs

aphasia

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

attention deficit disorder with hyperactivity

atypical

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autonomic dysfunction

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

bent spine syndrome

beta adrenergic blocker

calcification, intracranial

calcium antagonist

calcium antagonist, side effects of

calculations

camptocormia

carbamazepine

carbon monoxide poisoning

CAT scan

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, isodense lesion with acute hemorrhage

CAT scan, muscle

catecholamine

central hypoventilation

central nervous system, infection of

cerebral cortical atrophy

cerebral ischemia

cerebral palsy

cerebral vasculature, calcification

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular accident, complications with

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

comprehension, impaired

compression fracture

conjugate gaze, forced

consanguinity

contractures, joint

convergence, impaired

conversion reaction

copper metabolism, abnormal

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

crying, pathologic

cultured skin fibroblasts

cyanide poison

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diagnostic criteria

differential diagnosis

diplopia

disability, neurological

diurnal variation

dopa responsive dystonia

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, causes of

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, axial

dystonia, cervical

dystonia, children

dystonia, classification

dystonia, delayed onset

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, psychogenic

dystonia, treatment of

dystonic reaction, acute

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, viral

encephalopathy

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

equinovarus

exercise

exercise-induced neurologic dysfunction

extrapyramidal

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

Fahr disease

falling

familial

fine motor function, impaired

flunarizine

fluoxetine

foot deformity

frontal behavioral spatial syndrome

frontal lobe, atrophy

gait disorder

gait, apraxic

galactorrhea

gamma amino butyric acid

gangliosidosis GM1

gaze palsy

gaze palsy, supranuclear

genetic diagnosis, prenatal

genetic neurologic disorders

genetic testing

gests antagoniste

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

grasp reflex

grimacing

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination, visual

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatosplenomegaly

heralding manifestation

HLA

hoarseness

homovanillic acid

human immunodeficiency virus type 1

iatrogenic neurologic disorders

inborn errors of metabolism

inclusion bodies, intranuclear

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

jaw jerk, abnormal

Kayser-Fleischer ring

kyphosis

language disorder in adults

laughing, pathologic

L-dopa

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

Lewy body disease, diffuse

lipid storage disorder of CNS

manganese intoxication

masked facies

medical-legal aspects of neurology

memory, defect of recent

memory, impairment of

meningitis

meningitis, carcinomatous

mental status, abnormal

metabolic disorder, primary

mitochondrial disease

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI

MRI pattern

MRI, abnormal

MRI, CAT scan compared to

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, mouse ears

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis

multiple system atrophy

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurochemistry

neurodegeneration with brain iron accumulation

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal intranuclear inclusion disease

next-generation sequencing

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

norepinephrine

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

opened mouth

ophthalmoplegia

optic atrophy

optokinetic nystagmus, abnormal

paraplegia, in flexion

parasomnia

paraspinal muscle

paraspinal muscle weakness

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, juvenile

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, on-off phenomena in

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

paroxysmal nonkinesigenic dyskinesia

pathologic reflex

patient information and support

penguin silhouette sign

penicillamine

personality change

phenothiazine

phenothiazine, dyskinesia associated with

phenylketonuria

Pick's disease

pigmentary retinopathy

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

POLG1 gene

polycythemia, secondary

pons, lesion of

postural abnormality

precipitating factors

primary familial brain calcification

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

propranolol

pseudobulbar palsy

pseudohypoparathyroidism

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

putamen, lesion of, bilateral

quadriplegia

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading problem, causes of

recurrent

Red flags

reflex sympathetic dystrophy

release phenomena

renal failure

repetition, impaired

respirations in CNS disease

restless leg syndrome

reversible neurologic disorder

saccadic eye movements, abnormal

salivation, excessive

scoliosis

seizure

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss

sensory loss, cortical

sensory tricks

sequencing difficulty

short stature

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

somnolence

spastic dysphonia

speech disorder

speech disorder, childhood

stimulation, deep brain

stimulation, thalamic

stooped posture

striatal encephalitis

striopallidodentate calcifications, familial idiopathic

subarachnoid hemorrhage

substantia nigra

suck reflex

swallow evaluation

symmetric brain lesions

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, lesion of-bilateral

torticollis, post traumatic

toxoplasmosis, CNS

trauma

treatment failure

treatment of neurologic disorder

tremor, post traumatic

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness, progressive

X-linked dystonia-parkinsonism syndrome

Showing articles 550 to 600 of 1676 << Previous Next >>

Cocaine-Induced Persistent Dyskinesias
Neurol 56:964-965, Weiner,W.J.,et al, 2001

MR Imaging Findings After Stereotactic Radiosurgery Using the Gamma Knife
AJR 176:1589-1595, Friedman,D.P.,et al, 2001

DBS and Diathermy Interaction Induces Severe CNS Damage
Neurol 56:1384-1386, Nutt,J.G.,et al, 2001

Stem-Cell Research: Drawing the Line
Lancet 358:163,217, Greenberg,D.S., 2001

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

Reversible Parkinsonism and MRI Diffusion Abnormalities in Cortical Venous Thrombosis
Neurol 57:364-366, Jenkins,M.,et al, 2001

Effects of Bilateral Subthalamic Nucleus Stimulation on Parkinsonian Gait
Neurol 57:144-146, Stolze,H.,et al, 2001

Effects of Bilateral Subthalamic Stimulation on Cognitive Function in Parkinson Disease
Arch Neurol 58:1223-1227,1205, Alegret,M.,et al, 2001

Limb Immobilization for the Treatment of Focal Occupational Dystonia
Neurol 57:405-409, Priori,A.,et al, 2001

Bilateral Pallidal Deep Brain Stimulation for Cervical and Truncal Dystonia
Neurol 57:557-558, Andaluz,N.,et al, 2001

Deep Brain Stimulation in the Treatment of Parkinson's Disease,A Cost-Effectiveness Analysis
Neurol 57:663-671, Tomaszewski,K.J.&Holloway,R.G., 2001

Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease
NEJM 345:956-963, The Deep-Brain Stimulation for Parkinson's Disease, 2001

Improved Accuracy of Clinical Diagnosis of Lewy Body Parkinson's Disease
Neurol 57:1497-1499, Hughes,A.J.,et al, 2001

Daytime Sleepiness and Other Sleep Disorders in Parkinson's Disease
Neurol 57:1392-1396, Ondo,W.G.,et al, 2001

Hallucinations in Parkinson's Disease
Lancet 358:1031-1032, Korczyn,A.D., 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Complete Genomic Screen in Parkinson Disease
JAMA 286:2239-2244, Scott,W.K.,et al, 2001

Complications of Gamma Knife Surgery for Parkinson Disease
Arch Neurol 58:1995-2002,1970, Okun,M.S.,et al, 2001

[123I]Beta-CIT SPECT Imaging Assessment of the Rate of Parkinson's Disease Progression
Neurol 57:2089-2094, Marek,K.,et al, 2001

Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001

Welding-Related Parkinsonism
Neurol 56:8-13,4, Racette,B.A.,et al, 2001

Involuntary Movements After Anterior Cerebral Artery Territory Infarction
Stroke 32:258-261, Kim,J.S., 2001

Parkinsonism as the Presenting Manifestation of HIV Infection: Improvement on HAART
Neurol 56:278-279, Hersh,B.P.,et al, 2001

Functional Correlates of Pallidal Stimulation for Parkinson's Disease
Ann Neurol 49:155-164,142, Fukuda,M.,et al, 2001

Thalamic Deep Brain Stimulation
Arch Neurol 58:218-222, Ondo,W.,et al, 2001

Pallidal Stimulation for Generalized Dystonia
J Neurosurg 92:453-456, Tronnier,V.M. &Fogel,W., 2000

Olanzapine and Clozapine Comparative Effects on Motor Function in Hallucinating PD Patients
Neurol 55:789-794, 748, Goetz,C.F. et al, 2000

Hemidystonia and Hemichoreoathetosis as an Initial Manifestation of Moyamoya Disease
Arch Neurol 57:1510-1512, Lyoo,C.H.,et al, 2000

Computerized Posturography Analysis of Progressive Suprnuclear Palsy
Arch Neurol 57:1464-1469, Ondo,W.,et al, 2000

Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

Treatment of Drug-Induced Psychosis with Quetiapine and Clozapine in Parkinson's Disease
Neurol 55:1753-1754, Dewey,R.B.Jr. & O'Suilleabhain,P.E., 2000

Selegiiline and Mortality in Subjects with Parkinson's Disease
Neurol 55:1785-1789,1770, Donnan,P.T.,et al, 2000

Evolution of Sporadic Olivopontocerebellar Atrophy Into Multiple System Atrophy
Neurol 55:527-532, Gilman,S. et al, 2000

Postanoxic Parkinsonism: Clinical, Radiologic, and Pathologic Correlation
Neurol 55:591-593, Li,J.Y. et al, 2000

What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000

Intrathecal Baclofen for the Treatment of Dystonia in Patients with Reflex Sympathetic Dystrophy
NEJM 343:625-630,654, van Hilten,B.J. et al, 2000

Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000

Failure of Long-Term Pallidal Stimulation Corrected by Subthalmaic Stimulation in PD
Neurol 55:728-730, Houeto,J.L. et al, 2000

Long-Term Follow-Up of Unilateral Pallidotomy in Advanced Parkinson's Disease
NEJM 342:1708-1714, Fine,J.,et al, 2000

Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000

Association Between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
NEJM 342:1560-1567, Lucking,C.B.,et al, 2000

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
JAMA 283:2674-2679, Ross,G.W.,et al, 2000

Depression in Parkinson's Disease
BMJ 320:1287-1288, Allain,H.,et al, 2000

The DYT1 Phenotype and Guidelines for Diagnostic Testing
Neurol 54:1746-1753,1718, Bressman,S.B.,et al, 2000

Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000

Quetiapine for L-Dopa-Induced Psychosis in PD
Neurol 54:1538, Weiner,W.J.,et al, 2000

A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000

Showing articles 550 to 600 of 1676 << Previous Next >>